NARI inarimedical.com Market Cap to Net Assets Ratio

Official company branding of Inari Medical Inc (NARI)

Inari Medical, Inc. (NARI) is developing partnerships with clinics to train physicians on ClotTriever, leveraging flexible component outsourcing. The company's P/BV ratio on GURU.Markets reflects valuation dynamics, where the value 10.69 captures the metric level for support analysis. The business generates revenue through the sale of innovative mechanical thrombectomy systems that remove blood clots from vessels without the use of aggressive drugs.

NARI Inari Medical Corp: Market Value to Book Value in the range 07/04/2022 - 03/01/2025
Original product of Inari Medical Inc

Investors are seeking fundamental value drivers by comparing market price to equity. This metric is calculated as the ratio of market capitalization to the book value of net assets. The price action of the market value to book capitalization ratio reflects the market premium for future growth. For Inari Medical, Inc. (NARI), the high valuation is justified by the patent protection of its mechanical thrombectomy systems. Exclusive contracts with GPOs create a sustainable barrier, capitalizing the technological advantage into market value.

Competitor analysis

DexCom, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc. NPCE|Market Capitalization to Net Assets Tactile Systems Technology Inc.|SANUWAVE - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Outset Medical Inc OM|Market Cap to Net Assets Ratio ELMD (Electromed)|LNSR - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio AVITA Medical, Inc. RCEL|PROF - Market Cap to Book Value Multiple|bairdmed.com - Market Capitalization to Book Value Ratio|EDAP TMS (EDAP) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio APYX|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Market Cap to Net Assets Ratio|Market Value to Book Value TELA (telabio.com)|CytoSorbents Corporation - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Sensus Healthcare Inc SRTS|ZYXI (Zynex Inc) - Market Capitalization to Book Value Ratio|ECOR - Market-to-Book Ratio|Market Capitalization to Book Value Ratio vicarioussurgical.com|Inspira Technologies (IINN) - Capitalization to Book Value Ratio|ICU: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRIDEX Corp.|Market Capitalization to Book Value Ratio INBS (Intelligent Bio Solutions)|Market Cap to Net Assets Ratio beyondair.net (XAIR)|Market Capitalization to Book Value Ratio PFSA (Profusa Inc)|STRATA Skin Sciences Inc. - Market Capitalization to Book Value Ratio|GCTK - Market Value to Book Value Ratio|nanovibronix.com (NAOV) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Venus Concept Corp VERO|Nuwellis Corp (NUWE) - Market Value to Book Value|Market Capitalization to Book Value Ratio AEMD (Aethlon Medical)|Market-to-Book Ratio ASXC|AVGR: Market Value to Book Value Ratio|Market Value to Equity Ratio BioSig Technologies BSGM|Market Cap to Net Assets Ratio CUTR (Cutera, Inc)|Market Capitalization to Book Value Ratio Know Labs Corporation KNW|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)